This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Asthma
  • /
  • MP29-02 (a novel intranasal formulation of azelast...

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety

Read time: 1 mins
Published:1st Jul 2012
Author: <p>Meltzer EO LaForce C, Ratner P, Price D, Ginsberg D, Carr W.</p>
Availability: Free full text
Ref.:Allergy Asthma Proc. 2012;33(4):324�32.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest